Heteronemin, a Scalarane Sesterterpenoid, Activates Apoptosis and Non-Apoptotic Ferroptosis and Inhibits Cytoprotective Autophagy in Oral Cancer Cells
Archivum Immunologiae et Therapiae Experimentalis · 2026
DOI: 10.2478/aite-2026-0016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archivum Immunologiae et Therapiae Experimentalis, 2026. Verfasst von Rovelyn Gallego und 9 weiteren Autor:innen. Beteiligte Einrichtung: PhD Program in Life Sciences, College of Life Science, Kaohsiung Medical University, Kaohsiung 807, Taiwan. Hauptthemen laut MEDLINE: Mouth Neoplasms, Sesterterpenes, Antineoplastic Agents, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Oral squamous cell carcinoma (OSCC) ranks 16th worldwide as the most common type of malignancy in head and neck cancer globally, and addressing it has been an ongoing but difficult pursuit, as treatment resistance is commonly reported. Hence, employing multiple cell death pathways is an emerging strategy in overcoming treatment resistance in OSCC. We investigate here the effect of heteronemin, a marine sesterterpenoid isolated from sponges, for its anti-cancer potential, hypothesizing that it can induce non-apoptotic cell death pathways to overcome apoptosis-resistant cells and elucidate the underlying mechanisms involved. Our results show that heteronemin significantly kills cancer cells via the induction of the intrinsic apoptotic pathway. It also triggers ferroptosis, down-regulating glutathione peroxidase 4 (GPX4) and upregulating markers of lipid peroxidation such as 4-hydroxynonenal and malondialdehyde. We demonstrate that increasing reactive oxygen species generation plays a central role in triggering these pathways. ensuring the death of the cancer cells despite a compensation attempt via inducing autophagy and modulating Nrf2. Our study is the first to demonstrate the complex but interesting role of heteronemin in killing OSCC cells: inducing apoptosis and switching to ferroptosis as the cells attempt to survive. It also inhibits protective autophagy, leaving OSCC cells incapable of protecting themselves from imminent death. This complex mechanism adds to the existing knowledge on the mechanism of heteronemin as a strong therapeutic compound to treat OSCC cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- PhD Program in Life Sciences, College of Life Science, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
- Department of Biotechnology, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
- Department of Biology, College of Mathematics and Natural Sciences, Caraga State University, Butuan City, Philippines.
- Department of Applied Chemistry, National Chiayi University, Chiayi 60004, Taiwan.
- Graduate Institute of Marine Biology, National Dong Hwa University, Pingtung 944, Taiwan.
- National Museum of Marine Biology and Aquarium, Pingtung 944, Taiwan.
ORCID-Profile: Chien-Chih Chiu
Zitieren
APA
Gallego, R., Hung, C. T., Hsu, S. K., Chang, Y. H., Chen, C. P., Shu, E. D., Chien, C. M., Lu, M. C., Ko, C. C., & Chiu, C. C. (2026). Heteronemin, a Scalarane Sesterterpenoid, Activates Apoptosis and Non-Apoptotic Ferroptosis and Inhibits Cytoprotective Autophagy in Oral Cancer Cells. Archivum Immunologiae et Therapiae Experimentalis. https://doi.org/10.2478/aite-2026-0016
Vancouver
Gallego R, Hung CT, Hsu SK, Chang YH, Chen CP, Shu ED, et al. Heteronemin, a Scalarane Sesterterpenoid, Activates Apoptosis and Non-Apoptotic Ferroptosis and Inhibits Cytoprotective Autophagy in Oral Cancer Cells. Archivum Immunologiae et Therapiae Experimentalis. 2026. doi:10.2478/aite-2026-0016
BibTeX
@article{Gallego2026,
author = {Gallego, Rovelyn and Hung, Chun-Tzu and Hsu, Sheng-Kai and Chang, Yi-Hua and Chen, Ciao-Ping and Shu, En-De and Chien, Ching-Ming and Lu, Mei-Chin and Ko, Ching-Chung and Chiu, Chien-Chih},
title = {Heteronemin, a Scalarane Sesterterpenoid, Activates Apoptosis and Non-Apoptotic Ferroptosis and Inhibits Cytoprotective Autophagy in Oral Cancer Cells},
journal = {Archivum Immunologiae et Therapiae Experimentalis},
year = {2026},
doi = {10.2478/aite-2026-0016}
}
EUVIMED